Stifel reiterates FormFactor stock rating after Teradyne deal
Investing.com reports that Stifel has maintained its Hold rating and $115 price target on FormFactor shares after the company announced a significant strategic investment from Teradyne. The deal involves Teradyne acquiring a $300 million stake, accounting for roughly 3% of FormFactor, with the aim of enhancing collaboration in semiconductor test operations.
The agreement is contingent upon obtaining regulatory approvals and follows FormFactor's recent share price decline of 7.8% over the past week, despite delivering a substantial 223% return over the last year. Analysts suggest FormFactor's stock is currently slightly above its fair value, boasting a strong financial health score.
Notably, Stifel highlights that Teradyne's earlier investment in a competing probe card company was part of a strategy to foster open ecosystems in test operations, rather than consolidating the industry. The latest injection of capital is seen as opportune as FormFactor's new probe card manufacturing facility in Texas commences ramp-up this quarter.
Stifel intends to engage with both companies during the SEMICON event to gather further insights on the partnership. Meanwhile, FormFactor reported second-quarter earnings surpassing market expectations, with adjusted earnings of $0.82 per share and revenue of $258.2 million, surpassing analysts' estimates of $0.61 per share and $240 million in sales.
This marks the company's third consecutive quarter of record revenue growth, driven by high-bandwidth memory, data center CPUs, and co-packaged optics. Gross margins also improved due to increased volumes and better factory utilization. Deutsche Bank initiated coverage of FormFactor with a buy rating and a price target of $200, citing the company's emerging role as a probe card supplier for Nvidia's GPUs at TSMC, potentially unlocking a market opportunity worth around $0.5 billion by 2026.
Cantor Fitzgerald also reaffirmed its Overweight rating, acknowledging strong demand and dismissing despecification concerns. Collectively, these developments indicate a favorable outlook for FormFactor in the semiconductor testing equipment sector. The article was produced with AI assistance and reviewed by a human editor.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- Stifel maintains Syndax stock rating after trial failure investing.com